The largest database of trusted experimental protocols

10 protocols using total gip

1

Taste and Lipid Metabolism Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
As taste stimuli, we used a “sweet solution” consisting of a mixture of 0.125% saccharin and 3% glucose (both Sigma-Aldrich, St Louis, MO) or a “bitter solution” consisting of 0.15% (0.0038 M) quinine hydrochloride (Sigma-Aldrich). The saccharin-glucose mixture is avidly ingested by rats [12] (link); the 0.15% quinine is strongly disliked–tasting it elicits negative hedonic responses (i.e., gapes and chin rubs) and it is almost completely avoided in two-bottle preference tests [7] (link). As an intragastric fat load, 20% intralipid was purchased from Sigma-Aldrich (Cat. No. I-141). Radioactive 14C-triolein was purchased from American Radiolabeled Chemicals Inc (St Louis, MO) and stored at −20°C until use.
The following enzymatic colorimetric kits or ELISA kits were used for the assay of blood components; triglycerides, ketones, glycerol and glucose from Cayman Chemical Co. (Ann Arbor, MI); non-esterified fatty acid from Wako Diagnostics (Richmond, VA); insulin from Alpco Diagnostics (Windham, NH); total GIP, total GLP-1 and leptin from Millipore (Billerica, MA); peptide YY and cholecystokinin from Phoenix Pharmaceuticals (Belmont, CA).
+ Open protocol
+ Expand
2

Biomarker Quantification by ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Insulin (PerkinElmer, Waltham, MA), total GIP (Millipore), intact GLP-1 (Meso Scale Discovery, Rockville, MD), glucagon (Millipore), and leptin (Millipore) were measured by ELISA or AlphaLISA (insulin only) kits. Cholesterol, triglycerides, and free fatty acids were measured using kits (Sigma-Aldrich).
+ Open protocol
+ Expand
3

Plasma Biomarkers Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected in serum separation tubes (BD Vacutainer® SST™, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and EDTA tubes (BD Vacutainer®, Becton, Dickinson and Company) containing a DPP-4 inhibitor (10 µL/mL of blood; Millipore, St. Charles, MO, USA), and centrifuged for 10 minutes at 1,500 g for 20 minutes at 4℃. Plasma glucose levels were analyzed using a YSI 2300 STAT Plus analyzer (YSI Inc., Yellow Springs, OH, USA) immediately after centrifugation. The serum and plasma samples were stored at -70℃ until assayed. Non-esterified fatty acids (NEFA) were measured by a colorimetric assay using a Hitachi analyzer (Hitachi, Tokyo, Japan), and the glucagon concentrations were measured by a radioimmunoassay (Siemens, Los Angeles, CA, USA). The concentrations of insulin (Alpco Diagnostics, Salem, NH, USA), total GLP-1 (Alpco Diagnostics), and total GIP (Millipore, Billerica, MA, USA) were measured by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions. We did not use the ethanol extraction method, and the amount of plasma used was 100 µL each.
+ Open protocol
+ Expand
4

Anthropometric and Metabolic Parameters

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anthropometric parameters and blood pressure were measured using standard methods. FPG, insulin, total cholesterol, triglycerides, and high density lipoprotein cholesterol were measured, and the results were obtained from the main database. Homeostasis model of assessment-insulin resistance (HOMA-IR) was defined as [fasting insulin (µU/mL)×fasting glucose (mmol/L)]/22.5. Homeostasis model of assessment-β cell function (HOMA-B) was calculated using (20×fasting insulin in µU/mL)/(fasting glucose in mmol/L-3.5) [14 (link)]. total GLP-1 and total GIP were measured in the stored samples. The plasma concentrations of total GLP-1 (ALPCO Diagnostics, Windham, NH, USA) and total GIP (Millipore Corp., Bedford, MA, USA) were measured without an ethanol extraction step by an enzyme-linked immunosorbent assay. Samples were frozen at -70℃ and never thawed until they were moved to Samsung Medical Center for analyses. The biochemical analysis of incretin hormones was performed in duplicate by a single trained technician in the Department of Laboratory Medicine and Genetics at the Samsung Medical Center.
+ Open protocol
+ Expand
5

Rat Plasma Analyte Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat plasma total GLP-1 (MesoScale Discovery, Rockville, MD, USA; Cat. No. K150JVC) and glucagon (MesoScale Discovery, Cat. No. K150HCC) were assayed using a sandwich ELISA assay kit, while total GIP (Millipore, Burlington, MA, USA; Cat. No. EZRMGIP-55K), total PYY (Crystal Chem, Elk Grove Village, IL, USA; Cat. No. 81502), and insulin (Crystal Chem, Cat. No. 90060) were assayed using standard ELISA assay kits. Plasma acetaminophen was assayed by a kit purchased from Sekisui Diagnostics (Lexington, MA, USA).
+ Open protocol
+ Expand
6

Measuring Glycemic Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma glucose concentrations were measured by the glucose oxidase method (YSI 2300 STAT Plus analyzer; YSI, Inc., Yellow Springs, OH, USA). Plasma insulin concentrations were measured by electrochemiluminescence immunoassay (Immulite 2000; Siemens, Munich, Germany). Plasma concentrations of total GLP‐1 (Alpco Diagnostics; Salem, NH, USA) and total GIP (Millipore, Billerica, MA, USA) were analyzed by enzyme‐linked immunosorbent assay. All assays were carried out according to the manufacturer's instructions.
+ Open protocol
+ Expand
7

Obese Mice Metabolic Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma, tissues, cell extracts and supernatants from control and obese mice were evaluated with specific Elisa kits for mature glucagon, insulin (Mercodia AB, Uppsala, Sweden), total GLP-1 and leptin (Meso Scale Discovery, Rockville, MD, USA) and total GIP (Millipore Corporation, Billerica, MA, USA) peptide detections as well as NEFA (Wako Diagnostics, Richmond, VA, USA) and HbA1c by the Siemens DCA systems Hemoglobin A1c (Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA).
+ Open protocol
+ Expand
8

Metabolic Biomarker Profiling in Fasting and Postprandial States

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasma and serum samples were obtained from the participants in a fasting state and after cookie meal ingestion, snap-frozen using liquid nitrogen, and immediately stored at −80 °C until the analysis was performed. glucagon, active GLP-1, and total GIP levels were measured by enzyme-linked immunosorbent assay (glucagon: Mercodia, Uppsala, Sweden; active GLP-1: Immune Biology Laboratories, Gunma, Japan; total GIP: Merck Millipore, Darmstadt, Germany). All of the other items were analyzed at LSI Medience, Co., Ltd. (Tokyo, Japan). Blood glucose was measured by an enzymatic method and insulin was measured by chemiluminescence immunoassay (CLIA).
+ Open protocol
+ Expand
9

Metabolic Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma and serum samples, collected from participants in the fasting state and after intake of the test meal and test beverages, were snap-frozen in liquid nitrogen and stored at −80 °C until the analyses. A plasma sample was used for glucose measurements, and a serum sample was used for insulin measurements. Samples for measurement of glucagon, active GLP-1, and total GIP were collected using BD P800 (Becton Dickenson, London, UK), and their levels were measured using ELISA kits (glucagon: Mercodia, Uppsala, Sweden; active GLP-1: Immune Biology Laboratories, Gunma, Japan; total GIP: Merck Millipore, Darmstadt, Germany). Coefficients of variation were intra-assay for glucagon: 2.3%, GLP-1: 5.3%, GIP: 9.6%; inter-assay for glucagon: 4.3%, GLP-1: 9.2%, GIP: 7.2%. All other indices were analyzed at LSI Medience, Co., Ltd. (Tokyo, Japan). Total AUCs for glucose, insulin, glucagon, C-peptide, GLP-1, and GIP were calculated using the trapezoidal rule. The Matsuda index of insulin sensitivity [25 (link),26 (link),27 (link)] was calculated from measurements obtained after the test meal consumption. The insulin and glucose measurements were used to calculate the HOMA-IR, HOMA-β, and AUCins×glu [28 (link),29 (link),30 (link)].
+ Open protocol
+ Expand
10

Metabolite and Hormone Analysis via ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hormones and metabolites were measured as previous reported (7) . Human total GLP-1 (7-36, 9-36) (AlpcoDiagnositics; Salem, NH, USA) and total GIP was measured (Merck Millipore, Watford, UK) using ELISA kits. PNPLA3 genotyping was performed on DNA extracted from white blood cells. DNA was isolated and genotyping performed using TaqMan SNP Genotyping Analysis (Applied Biosystems, USA) as described previously (22) .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!